| Ytd | 7.27% | |
| 1y | -31.40% |
| Open | 2.96 | Prev Close | 2.98 | Low | 2.93 | High | 3.00 | Mkt Cap | 230.21M |
| Vol | 58.13K | Avg Vol | 1.84M | EPS | -1.41 | P/E | -2.11 | Forward P/E | -2.91 |
| Beta | 1.74 | Short Ratio | 4.69 | Inst. Own | 81.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 3.38 | 200-d Avg | 3.58 | 1yr Est | 16.15 |
Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us,
Here is how Perspective Therapeutics (CATX) and Charles River Laboratories (CRL) have performed comp
U.S. stock futures mixed, Nasdaq 100 up 100 pts. Telefonaktiebolaget LM Ericsson falls 9.2% in pre-m